Summary
Swiss Federal Institute of Technology Zurich (ETH Zurich) is an educational university that offers studies in technology and the natural sciences. The university provides scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architecture, biology, agricultural science, agroecosystem science, biomedical engineering, and food science among others. It offers research in various disciplines such as world food system, health, risk research, information processing, cities of the future, climate change, energy, new materials and industrial processes, through several competence centres. ETH Zurich also provides continuing education services and other non degree courses. The university offers technology transfer by providing research projects with industry, licensing opportunities, innovation and setting up companies. ETH Zurich is headquartered in Zurich, Switzerland.
Swiss Federal Institute of Technology Zurich - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Swiss Federal Institute of Technology Zurich, Medical Devices Deals, 2010 to YTD 2016 9
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Boehringer Ingelheim Enters Into Research Agreement With ETH Zurich 12
CovalX Enters Into Agreement With Swiss Federal Institute of Technologie For Epitope Mapping 13
Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University Hospital Zurich 14
IBM Enters Into Research Agreement With ETH Zurich And CloudBroker 16
McGill University Forms Joint Venture With University Of Zurich And Swiss Federal Institute Of Technology 17
AB SCIEX Partners With ETH Zurich Institute of Molecular Systems Biology 19
Licensing Agreements 21
Biognosys Enters into Licensing Agreement with ETH Zurich Foundation 21
Dualsystems Biotech Enters Into Licensing Agreement With ETH Zurich For Ligand Receptor Capture Technology 22
Swiss Federal Institute Of Technology Enters Into Licensing Agreement With Cell Culture Technologies 23
CovalX Enters Into Licensing Agreement With ETH Zurich For Cross Linking Molecule Patents 24
Swiss Federal Institute of Technology Zurich - Key Competitors 25
Key Employees 26
Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Tables
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Key Facts 1
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Swiss Federal Institute of Technology Zurich, Deals By Therapy Area, 2010 to YTD 2016 8
Swiss Federal Institute of Technology Zurich, Medical Devices Deals, 2010 to YTD 2016 9
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Boehringer Ingelheim Enters Into Research Agreement With ETH Zurich 12
CovalX Enters Into Agreement With Swiss Federal Institute of Technologie For Epitope Mapping 13
Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University Hospital Zurich 14
IBM Enters Into Research Agreement With ETH Zurich And CloudBroker 16
McGill University Forms Joint Venture With University Of Zurich And Swiss Federal Institute Of Technology 17
AB SCIEX Partners With ETH Zurich Institute of Molecular Systems Biology 19
Biognosys Enters into Licensing Agreement with ETH Zurich Foundation 21
Dualsystems Biotech Enters Into Licensing Agreement With ETH Zurich For Ligand Receptor Capture Technology 22
Swiss Federal Institute Of Technology Enters Into Licensing Agreement With Cell Culture Technologies 23
CovalX Enters Into Licensing Agreement With ETH Zurich For Cross Linking Molecule Patents 24
Swiss Federal Institute of Technology Zurich, Key Competitors 25
Swiss Federal Institute of Technology Zurich, Key Employees 26
Swiss Federal Institute of Technology Zurich, Subsidiaries 27
List of Figures
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Swiss Federal Institute of Technology Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Swiss Federal Institute of Technology Zurich, Medical Devices Deals, 2010 to YTD 2016 9
